Predicting relapse in ulcerative colitis with early stool tests
Part of Digestive system clinical trials.
This study looks at whether early stool tests (fecal immunochemical test and calprotectin) can predict when ulcerative colitis symptoms might return. It is for people who have never taken biologic medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with ulcerative colitis, confirmed by a colonoscopy and biopsy.
- Your ulcerative colitis is moderately to severely active (Mayo score of 2 or higher on colonoscopy).
- You have never taken biologic drugs (like infliximab, adalimumab, vedolizumab, or ustekinumab) or JAK inhibitors.
- You have not used steroid medications (oral or IV) in the 4 weeks before starting the study.
- You are not taking blood thinners (like aspirin, clopidogrel, warfarin, or rivaroxaban) regularly.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at stool samples to see if certain markers can quickly tell whether a biologic medicine is starting to work for moderate-to-severe ulcerative colitis. If successful, this could help doctors make faster, smarter treatment decisions.
This study tests whether using a simple stool test to guide treatment is better than usual care for people with ulcerative colitis in remission. It aims to keep you in remission longer and prevent flare-ups.
This study looks at whether a simple stool test can tell if treatment is healing the gut lining in people with moderate to severe ulcerative colitis who are starting their first biologic medicine. If it works, this test might help doctors adjust treatment earlier.
This study looks at whether stool tests, combined with a special camera test of the colon, can help find early signs of colon changes in people who have had ulcerative colitis for a long time. It aims to improve how we monitor for any serious changes like cancer.
This study looks at gut barrier function in people with ulcerative colitis who are in remission. It uses a non-invasive liver test to check for subtle changes in the body.
This study tests whether a substance in your urine can help measure how active your ulcerative colitis is. Researchers hope this simple urine test might become a useful tool to track your disease without more invasive procedures.
Hear when a new FIT trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.